SPRB Stock Analysis: Buy, Sell, or Hold?
SPRB - Spruce Biosciences, Inc. Common Stock
$52.51
-0.04 (-0.07%)
▼
5d:
-0.49%
30d:
+6.51%
90d:
-24.48%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When SPRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SPRB trading at deep discount. Market pricing in -17.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SPRB trading at deep discount. Market pricing in -17.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$131.78
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$81.83
35.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SPRB is currently trading at $52.51, which is considered slightly high relative to its 30-day fair value range of $48.85 to $53.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.6) compared to its historical average (19.0). Remarkably, the market is currently pricing in an annual earnings decline of 17.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $46.70, while resistance sits at $54.32.
Market Sentiment: SPRB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $149.71 (+185.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $46.70, while resistance sits at $54.32.
Market Sentiment: SPRB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $149.71 (+185.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$48.85 -
$53.41
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 185.1% below Wall St target ($149.71)
Trading Range Analysis
30-Day Trading Range
$48.85 -
$53.41
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$46.70
Resistance Level
$54.32
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.61
Wall Street Target
$149.71
(+185.1%)
Revenue Growth (YoY)
-75.9%
Valuation Discount vs History
-17.6% cheaper
PE vs Historical
10.6 vs 19.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.6%
(market-implied from PE analysis)
1-Year Target
$47.26
(-10%)
2-Year Target
$42.53
(-19%)
3-Year Target
$38.28
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→19)
$68.56
(+31%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.6 to 19.0
Stabilization Target:
$94.05
(+79.1%)
PE Expansion Potential:
+79.1%
Share & Embed Analysis
Last updated: July 03, 2026 6:08 PM ET
Data refreshes hourly during market hours. Next update: 7:08 PM
Data refreshes hourly during market hours. Next update: 7:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
